|Articles|March 27, 2018

First Report of East Asian Tick Species in the United States

The first documentation of the east Asian tick Haemaphysalis longicornis in the United States has been described in a recent study.

A recent study has described the first documentation of the east Asian tick Haemaphysalis longicornis in the United States, on a sheep in Hunterdon County, New Jersey.

Tadhgh Rainey, MS, the division head of the Hunterdon County Division of Health, Flemington, New Jersey, and colleagues published the results of their study online February 19, 2018, in the Journal of Medical Entomology.

“This is the first description of multiple life stages of H. longicornis infesting an animal within the United States, although single specimens have been occasionally intercepted at quarantine stations, including a single specimen on a horse at a quarantine station in Clifton, NJ in 1969,” the authors write.

Also known as the cattle tick, longhorned tick, or bush tick, H. longicornis is native to East Asia. Until now, H. longicornis had not been found on an unquarantined animal in the United States, but it is known to be a major invasive pest in other regions of the world—namely New Zealand, parts of Australia, and some of the Pacific islands. Cases of H. longicornis infestation in individuals have also been reported in these regions, as well as in Russia and South Korea.

This tick species has been described as self-cloning because it reproduces asexually by parthenogenesis, allowing it to multiply quickly. Although it feeds on the blood of various mammals, H. longicornis is best known as a pest of livestock. In particular, heavy infestations of this tick in cattle can lead to weakness, and, in extreme cases, exsanguination and death.

In New Zealand, H. longicornis is the main vector for Theileria orientalis (Ikeda). This blood-borne theilerian parasite causes Theileria-associated bovine anemia and was first identified in beef cattle and dairy cattle in New Zealand in 2012.

In East Asia, H. longicornis has also been linked to the spread of a newly-described phlebovirus that causes Severe Fever with Thrombocytopenia Syndrome (SFTS). This emerging hemorrhagic fever is associated with a wide spectrum of clinical signs and symptoms, including fever, thrombocytopenia, and leukocytopenia, with a case fatality rate of between 12% and 30%.

In this case in New Jersey, a sheep owner took samples of ticks from her 12-year-old Icelandic sheep to the Hunterdon County Health Department in August 2017. The sheep was infested by hundreds of ticks, including all 3 active life stages (larva, nymph, adult). The ticks were present all over the sheep’s body but were concentrated on the ears and face.

According to the owner, the sheep had no history of travel outside the United States.

Researchers identified the ticks as belonging to the genus Haemaphysalis but found that the specimens were not consistent with any of the species of Haemaphysalis that are native to the Western Hemisphere. Indeed, further analysis identified the ticks as Haemaphysalis longicornis.

The owner treated the sheep using a permethrin wash in late September, and the animal was found to be free of ticks at follow-up examinations in early and late November.

“It is currently unknown whether the New Jersey collections represent a limited or established population, but because this species could present a significant threat to human and animal health in the United States, vigilance is encouraged,” the authors conclude.

Dr. Parry graduated from the University of Liverpool, England in 1997 and is a board-certified veterinary pathologist. After 13 years working in academia, she founded Midwest Veterinary Pathology, LLC where she now works as a private consultant. She is passionate about veterinary education and serves on the Indiana Veterinary Medical Association’s Continuing Education Committee. She regularly writes continuing education articles for veterinary organizations and journals and has also served on the American College of Veterinary Pathologists’ Examination Committee and Education Committee.

Feature Picture Source: Patrick O' Sulivan / flickr / Creative Commons .


Related to this article

Ebola and the Ongoing Tale of US Failures
In mid-May, as the world was still grappling with an unexpected hantavirus outbreak aboard a tourism vessel, news broke of an Ebola outbreak in the Ituri Province of the Democratic Republic of the Congo spanning at least 3 health zones, including Bunia, Rwampara, and Mongbwalu.
CDC Responds to Surge in Rabies Exposures
A "Clinician Outreach" from the Centers for Disease Control and Prevention (CDC) in April anticipated an increase in rabies exposures, and the striking surge in case reports this summer prompted a recent health advisory alert from the federal agency.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Measles Update: September 18, 2026
The latest CDC numbers show a 5.37% increase of measles cases from week-to-week. In Pennsylvania, the fourth measles-related death was reported in 2026. Additionally, the CDC has made a change in the way it will report deaths.
New Diagnositics for Legionella Pneumonia May Streamline Care Continuum
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.